Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma. (Q54308330)
Jump to navigation
Jump to search
scientific article published on 25 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma. |
scientific article published on 25 November 2014 |
Statements
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma. (English)
Anthony W Tolcher
Amita Patnaik
Kyriakos P Papadopoulos
Drew W Rasco
Carlos R Becerra
Alicia J Allred
Keith Orford
Gursel Aktan
Geraldine Ferron-Brady
Nageatte Ibrahim
Jennifer Gauvin
Monica Motwani
Mark Cornfeld
25 November 2014
75
1
183-189
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference